-
Symbol
-
AUTL on Nasdaq
-
Investment type
-
Equity / Ordinary Shares, par value NIS 0.40 per share
-
Latest Disclosed Ownership
-
28.8M shares
-
Security Ownership
-
10.8%
Shares, Excluding Options vs Price
Value, Excluding Options
Syncona Portfolio Limited ownership in Autolus Therapeutics plc Ordinary Shares, par value NIS 0.40 per share (AUTL)
2025-05-07 - Syncona Portfolio Limited has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 28.8M shares of Autolus Therapeutics plc Ordinary Shares, par value NIS 0.40 per share (AUTL).
This represents 10.8% percent ownership of the company.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.